Author:
Maksymowych Walter P.,Weber Ulrich
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. • Rudwaleit M, Haibel H, Baraliakos X, Listing J, et al. The early disease stage in axial Spondylarthritis. Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009; 60:717–727. This prospective study shows that SpA patients with preradiographic disease experience similar severity of symptoms to those with established AS.
2. • Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27–positive patients with magnetic resonance imaging–determined early sacroiliitis. Arthritis Rheum 2009; 60: 946–954. This randomized controlled trial in very early SpA diagnosed by MRI demonstrated exceptional clinical responses to infliximab.
3. • Hildrun H, Rudwaleit M, Listing J, et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis. Arthritis Rheum 2008; 58: 1981–1991. This randomized controlled trial of adalimumab showed that ASAS20 responses are even higher in preradiographic SpA than previously demonstrated in pivotal phase 3 trials of anti-TNF agents.
4. •• Rudwaleit M, van der Heijde D, Landewé R, et al. The development of assessment of SpondyloArthritis international Society (ASAS) Classification Criteria for axial spondyloarthritis (Part II): validation and final selection. Ann Rheum Dis 2009; 68: 777–783. This final study report describes the final selection of items and validation of the new ASAS axial SpA criteria. A notable inclusion is the addition of MRI as an imaging criterion for patients who do not have radiographic sacroiliitis.
5. Rudwaleit M, Jurik AG, Hermann KG, Landewé R, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis—a consensual approach by the ASAS/OMERACT MRI Group. Ann Rheum Dis. 2009;68:1520–7.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献